Obermann and colleagues have recently reported that pregabalin, a new drug that reduces release of excitatory neurotransmitters, shows promise as a treatment for TN. Their prospective, open-label ...

Purpose: The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and dosage and administration of pregabalin are reviewed. Summary: Pregabalin is the first drug to receive approved ...